Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Theta Phase-specific TMS to Modulate Prefrontal Activity | Clinical Trials | Clareo Health

Back to search

COMPLETEDNA

Theta Phase-specific TMS to Modulate Prefrontal Activity

The Effects of Closed-loop TMS-EEG on Immediate Prefrontal Activity and Approach/Avoidance Behavior

NCT05416138•University of Minnesota

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Approach/Avoidance Behavior

Interventions

Transcranial magnetic stimulation (TMS)

Locations

United States

Locations (1)

University of Minnesota

Minneapolis, Minnesota, United States

Key Dates

Start Date

November 1, 2022

Primary Completion Date

August 31, 2024

Completion Date

August 31, 2024

Last Updated

December 10, 2025

Sponsors

Lead Sponsor

University of Minnesota

Collaborators

National Institute of Mental Health (NIMH)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 10, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions